Clinical Trial Update: A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCV [Phase 2]

View source ↗

Summary

Phase 2 results assess the safety and efficacy of Bemnifosbuvir and Ruzasvir in adults with chronic hepatitis C, including patients with liver cirrhosis; result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Liver Cirrhosis

Drugs mentioned

• Bemnifosbuvir (bemnifosbuvir)
• Ruzasvir (ruzasvir)

Snippet

Sponsor: Atea Pharmaceuticals, Inc. | Conditions: Chronic Hepatitis C Virus, Hepatitis C, Chronic | Phase 2 | Status: COMPLETED | Results posted: 2025-10-21